Mirum Pharmaceuticals, Inc. MIRM Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Mirum Pharmaceuticals, Inc. (MIRM) reported deferred tax assets and other non-current assets of $16.18M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets increased by 195.6% year-over-year, from $5.47M to $16.18M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets has grown at a 56.7% compound annual growth rate (CAGR), from $1.27M to $12.02M.